Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients
Clinical trial NCT06685653 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06685653
- Sponsor
- Nanjing Tianyinshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Primary completion
- 2026-11-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.